![Kris Siemionow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kris Siemionow
Directeur Général chez Holo Surgical, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Pawel Lewicki | M | 70 |
Holo Surgical, Inc.
![]() Holo Surgical, Inc. Medical SpecialtiesHealth Technology Holo Surgical, Inc. engages in operation of a digital surgery company. Its technology focuses on improving patient outcomes by bringing Augmented Reality and Artificial Intelligence to the operating room. The company was founded by Cristian Luciano and Kris Siemionow in 2015 and is headquartered in Chicago, IL.
Dystrogen Therapeutics Corp.
![]() Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | 8 ans |
Maria Siemionow | M | - |
Dystrogen Therapeutics Corp.
![]() Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | 7 ans |
Cristian Luciano | M | - |
Holo Surgical, Inc.
![]() Holo Surgical, Inc. Medical SpecialtiesHealth Technology Holo Surgical, Inc. engages in operation of a digital surgery company. Its technology focuses on improving patient outcomes by bringing Augmented Reality and Artificial Intelligence to the operating room. The company was founded by Cristian Luciano and Kris Siemionow in 2015 and is headquartered in Chicago, IL. | 9 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Edyta Niemczyk | M | - |
Dystrogen Therapeutics Corp.
![]() Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 4 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Kris Siemionow
- Réseau Personnel